Halozyme Therapeutics Inc (HALO) — Free Cash Flow Generation Index
Halozyme Therapeutics Inc (HALO) has a Free Cash Flow Generation Index of 0.98x as of September 2025. Free cash flow of $175.57 Million represents 1% of operating cash flow ($178.60 Million). Explore Halozyme Therapeutics Inc (HALO) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Halozyme Therapeutics Inc Free Cash Flow Generation Index (2006–2024)
Historical FCF Generation Index trend for Halozyme Therapeutics Inc across 7 annual periods. For the full cash flow conversion analysis, see Halozyme Therapeutics Inc (HALO) cash conversion ratio.
Annual Free Cash Flow Generation for Halozyme Therapeutics Inc (2006–2024)
Year-by-year Free Cash Flow Generation Index for Halozyme Therapeutics Inc. Check HALO cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.98x | $468.37 Million | $479.06 Million | $10.70 Million | ▲ +1.8% |
| 2023 | 0.96x | $373.28 Million | $388.57 Million | $15.29 Million | ▼ -2.0% |
| 2022 | 0.98x | $235.30 Million | $240.11 Million | $4.81 Million | ▼ -1.5% |
| 2021 | 1.00x | $297.98 Million | $299.44 Million | $1.46 Million | ▲ +4.2% |
| 2020 | 0.95x | $52.95 Million | $55.45 Million | $2.50 Million | ▼ -3.5% |
| 2017 | 0.99x | $132.70 Million | $134.05 Million | $1.35 Million | ▲ +4.4% |
| 2006 | 0.95x | $6.71 Million | $7.08 Million | $364.80K | — |